Nishitsuji Hironori, Ikeda Tamako, Miyoshi Hiroyuki, Ohashi Takashi, Kannagi Mari, Masuda Takao
Department of Immunotherapeutics, Graduate School of Medicine and Dentistry, Tokyo Medical and Dental University, 1-5-45 Yushima, Tokyo 113-8519, Bunkyo-ku, Japan
Microbes Infect. 2004 Jan;6(1):76-85. doi: 10.1016/j.micinf.2003.10.009.
RNA interference (RNAi) is a sequence-specific RNA degradation process mediated by short double-stranded RNAs termed small interfering RNAs. Here, we describe the lentivirus-based vector small interfering RNA system expressing. As a pilot study, we generated constructs expressing small hairpin RNA (shRNA) specific for luciferase gene (shLuc) or green fluorescence protein (shGFP) under the control of human H1 RNA polymerase III promoter. The effect of the shRNA was evaluated against HIV-1 infection in a single-round or multiple-round infectious system using an HIV-1 molecular clone carrying the luc or GFP gene. In the single-round infectious system, cells transduced with shLuc by lentiviral vector significantly reduced (approximately 90% reduction) viral gene expression after challenge infection at a multiplicity of infection of 10. These transduced cells continued to resist against at least four sequentially repeated challenge infections. Importantly, this efficient antiviral activity persisted over 35 days in culture. In a multiple-round infectious system using a replication-competent HIV-1 molecular clone carrying the GFP gene, we also observed that a lentiviral vector expressing shGFP could inhibit HIV-1 replication for at least 1 week. The profound effect of lentiviral shRNA was also observed in human primary monocyte-derived macrophages. Thus, shRNA introduced through the lentiviral vector can be useful for efficient and stable gene suppression in human cells including primary non-dividing cells. Moreover, quantitative analysis of viral cDNA synthesis on challenge infection showed that viral genomic RNAs packaged in incoming virus core might not be targeted by shLuc. Instead, the degradation of transcripts from integrated proviral DNAs might be a major cause of the profound reduction in HIV-1 gene expression by shRNA in our system.
RNA干扰(RNAi)是一种由称为小干扰RNA的短双链RNA介导的序列特异性RNA降解过程。在此,我们描述了基于慢病毒载体的小干扰RNA表达系统。作为一项初步研究,我们构建了在人H1 RNA聚合酶III启动子控制下表达针对荧光素酶基因(shLuc)或绿色荧光蛋白(shGFP)的小发夹RNA(shRNA)的构建体。使用携带luc或GFP基因的HIV-1分子克隆,在单轮或多轮感染系统中评估shRNA对HIV-1感染的影响。在单轮感染系统中,用慢病毒载体转导shLuc的细胞在感染复数为10的攻击感染后,病毒基因表达显著降低(约降低90%)。这些转导的细胞继续抵抗至少四次连续重复的攻击感染。重要的是,这种有效的抗病毒活性在培养中持续超过35天。在使用携带GFP基因的具有复制能力的HIV-1分子克隆的多轮感染系统中,我们还观察到表达shGFP的慢病毒载体可以抑制HIV-1复制至少1周。在人原代单核细胞衍生的巨噬细胞中也观察到了慢病毒shRNA的显著作用。因此,通过慢病毒载体引入的shRNA可用于在包括原代非分裂细胞在内的人类细胞中进行高效稳定的基因抑制。此外,对攻击感染时病毒cDNA合成的定量分析表明,包装在进入病毒核心中的病毒基因组RNA可能不是shLuc的靶标。相反,整合的前病毒DNA转录本的降解可能是我们系统中shRNA导致HIV-1基因表达大幅降低的主要原因。